Chan Zuckerberg Initiative injects funds into Galaxy platform for biomedical research
The global Galaxy Project has been awarded a US$190,000 grant by the Chan Zuckerberg Initiative (CZI) to extend Galaxy—a web-based computational platform—so that it can analyse large biomedical datasets and integrate with other analysis tools.
The grant will be used to
extend Galaxy to allow easy browsing and importing of datasets from large data repositories
enable Galaxy to efficiently use cloud computing resources for large-scale, near-data computing
extend Galaxy integration with other data science environments.
Read More
New investment to improve human genomics data sharing for research in Australia
A new investment from the Australian Research Data Commons (ARDC), Australian BioCommons and multiple partner organisations will transform how human genomics data for research is shared by bringing the best global technologies and standards to Australia. Through this new project, genomic data from thousands of Australians will be able to be shared securely and responsibly on national and global scales, enabling comparison with very large numbers of other genomes to ensure their full research value can be realised.
Read More
CloudStor integration for Galaxy Australia is now live
Life sciences researchers using the Galaxy Australia analysis platform can now easily and securely move their data to and from the AARNet CloudStor research data storage platform.
This new integration is helping to streamline workflows for Australian researchers collaborating nationally and internationally on projects across the sciences and humanities that aim to solve some of the biggest problems facing our planet.
Read More
Hear about our latest developments at eResearch Australasia
Many of the Australian BioCommons team and partners working on our projects will be presenting at the next eResearch conference. Here’s a grab of ways to hear about our ongoing developments…
Read More
Associate Directors of the Australian BioCommons
Meet our Associate Directors and learn what excites them about our work.
Read More
Rapid genome assembly on Gadi at NCI
The Australian BioCommons is identifying community-supported bioinformatics tools used for assembly of non-model organism reference genomes, and subsequently coordinating the install, optimisation and documentation of these tools across Australian computing facilities, including the national (tier 1) high performance computing centres. A major aim is to provide reusable and reproducible methods that can be applied across these and other infrastructures available to the genome assembly community.
Read More
Bioplatforms Australia charges Australian BioCommons with addressing our national bioinformatics challenges
The Australian BioCommons is proud to announce the signing of a contract with Bioplatforms Australia to deliver enhanced coordination in the planning and development of research infrastructure supporting bioinformatics in life science research. The $20M NCRIS investment will improve the ability of many of Australia’s best researchers to undertake leading edge bioinformatics analyses. The Australian BioCommons is partnering with a network of Australian and global bioinformatics and data intensive research groups to address high priority challenges through to 2023.
Read More
New strategic collaboration with ELIXIR
A new Collaboration Strategy between ELIXIR and the Australian BioCommons seeks to create a cooperative plan to exploit international synergies between the two research infrastructures. This three-year collaboration will actively involve Australian BioCommons in many of the activities related to the European life science infrastructures.
Read More
Australian BioCommons partners with international collaboration focused on personalised treatment for kids with cancer
Industry-leading bioinformatics ecosystem provider, Seven Bridges, sparked international interest this week in the multinational genomic cancer research project that Australian BioCommons contributes to. Their media release Seven Bridges Announces International Collaboration Focused on Personalized Treatment for Kids with Cancer documented how our collaboration will help researchers better understand rare pediatric brain cancer subtypes and improve interventions for patients and their families. Working with Seven Bridges, The Gabriella Miller Kids First Data Resource Center (Kids First DRC), ZERO Childhood Cancer (ZERO), the Children’s Brain Tumor Tissue Consortium (CBTTC) and the Australian Research Data Commons (ARDC), we are establishing internationally federated computational infrastructure that will enable the harmonisation of pediatric cancer data from ZERO Australia with the extensive genomic datasets from CBTTC and Kids First DRC.
Read More
NEWS RELEASE: Seven Bridges Announces International Collaboration Focused on Personalized Treatment for Kids with Cancer
Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced a collaborative partnership between The Gabriella Miller Kids First Data Resource Center (Kids First DRC), ZERO Childhood Cancer (ZERO), the Children’s Brain Tumor Tissue Consortium (CBTTC), the Australian BioCommons and the Australian Research Data Commons (ARDC). The multinational genomic cancer research project aims to establish internationally federated computational infrastructure that will enable the harmonization of pediatric cancer data from ZERO Australia with the extensive genomic datasets from CBTTC and Kids First DRC. Through this collaboration, researchers hope to better understand rare pediatric brain cancer subtypes and improve interventions for patients and their families.
Read More